{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T07:24:02Z","timestamp":1780471442405,"version":"3.54.1"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,30]],"date-time":"2021-09-30T00:00:00Z","timestamp":1632960000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,9,30]],"date-time":"2021-09-30T00:00:00Z","timestamp":1632960000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Susac syndrome (SS) is characterized by the triad of encephalopathy, branch retinal artery occlusion, and sensorineural hearing loss. However, the diagnosis of SS remains difficult because the clinical triad rarely occurs at disease onset, and symptom severity varies. SS symptoms often suggest other diseases, in particular multiple sclerosis (MS), which is more common. Misdiagnosing SS as MS may cause serious complications because MS drugs, such as interferon beta-1a, can worsen the course of SS. This case report confirms previous reports that the use of interferon beta-1a in the course of misdiagnosed MS may lead to exacerbation of SS. Moreover, our case report shows that glatiramer acetate may also exacerbate the course of SS. To the best of our knowledge, this is the first reported case of exacerbation of SS by glatiramer acetate.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>We present a case report of a patient with a primary diagnosis of MS who developed symptoms of SS during interferon beta-1a treatment for MS; these symptoms were resolved after the discontinuation of the treatment. Upon initiation of glatiramer acetate treatment, the patient developed the full clinical triad of SS. The diagnosis of MS was excluded, and glatiramer acetate therapy was discontinued. The patient\u2019s neurological state improved only after the use of a combination of corticosteroids, intravenous immunoglobulins, and azathioprine.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The coincidence of SS signs and symptoms with treatment for MS, first with interferon beta-1a and then with glatiramer acetate, suggests that these drugs may influence the course of SS. This case report indicates that treatment with glatiramer acetate may modulate or even exacerbate the course of SS.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12886-021-02101-3","type":"journal-article","created":{"date-parts":[[2021,9,30]],"date-time":"2021-09-30T05:03:54Z","timestamp":1632978234000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Manifestation of Susac syndrome during interferon beta-1a and glatiramer acetate treatment for misdiagnosed multiple sclerosis: a case report"],"prefix":"10.1186","volume":"21","author":[{"given":"Joanna","family":"Roskal-Wa\u0142ek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micha\u0142","family":"Biskup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Dolecka-\u015alusarczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Roso\u0142owska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrzej","family":"Jaroszy\u0144ski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominik","family":"Odrobina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,30]]},"reference":[{"key":"2101_CR1","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1007\/s00415-014-7628-9","volume":"262","author":"KA Buzzard","year":"2015","unstructured":"Buzzard KA, Reddel SW, Yiannikas C, Sean Riminton D, Barnett MH, Hardy TA. Distinguishing Susac\u2019s syndrome from multiple sclerosis. J Neurol. 2015;262:1613\u201321.","journal-title":"J Neurol"},{"key":"2101_CR2","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1097\/WNO.0000000000000677","volume":"39","author":"RA Egan","year":"2019","unstructured":"Egan RA. Diagnostic Criteria and Treatment Algorithm for Susac Syndrome. J Neuroophthalmol. 2019;39:60\u20137.","journal-title":"J Neuroophthalmol"},{"key":"2101_CR3","doi-asserted-by":"publisher","first-page":"5779","DOI":"10.1038\/s41467-019-13593-5","volume":"10","author":"CC Gross","year":"2019","unstructured":"Gross CC, Meyer C, Bhatia U, Yshii L, Kleffner I, Bauer J, et al. CD8 + T cell-mediated endotheliopathy is a targetable mechanism of neuro-inflammation in Susac syndrome. Nat Commun. 2019;10:5779.","journal-title":"Nat Commun"},{"key":"2101_CR4","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1080\/00207454.2016.1254631","volume":"127","author":"T Seifert-Held","year":"2017","unstructured":"Seifert-Held T, Langner-Wegscheider BJ, Komposch M, Simschitz P, Franta C, Teuchner B, et al. Susac\u2019s syndrome: clinical course and epidemiology in a Central European population. Int J Neurosci. 2017;127:776\u201380.","journal-title":"Int J Neurosci"},{"key":"2101_CR5","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1177\/1971400917712265","volume":"31","author":"H Algahtani","year":"2018","unstructured":"Algahtani H, Shirah B, Amin M, Altarazi E, Almarzouki H. Susac syndrome misdiagnosed as multiple sclerosis with exacerbation by interferon beta therapy. Neuroradiol J. 2018;31:207\u201312.","journal-title":"Neuroradiol J"},{"key":"2101_CR6","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1001\/archophthalmol.2011.1841","volume":"130","author":"PW Laird","year":"2012","unstructured":"Laird PW, Newman NJ, Yeh S. Exacerbation of Susac syndrome retinopathy by interferon Beta-1a. Arch Ophthalmol. 2012;130:804\u20136.","journal-title":"Arch Ophthalmol"},{"key":"2101_CR7","doi-asserted-by":"publisher","first-page":"e151","DOI":"10.1212\/NXI.0000000000000151","volume":"2","author":"L Zhovtis Ryerson","year":"2015","unstructured":"Zhovtis Ryerson L, Kister I, Snuderl M, Magro C, Bielekova B. Incomplete Susac syndrome exacerbated after natalizumab. Neurol Neuroimmunol Neuroinflamm. 2015;2:e151.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"2101_CR8","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/nrneurol.2013.82","volume":"9","author":"J D\u00f6rr","year":"2013","unstructured":"D\u00f6rr J, Krautwald S, Wildemann B, Jarius S, Ringelstein M, Duning T, et al. Characteristics of Susac syndrome: a review of all reported cases. Nat Rev Neurol. 2013;9:307\u201316.","journal-title":"Nat Rev Neurol"},{"key":"2101_CR9","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1136\/jnnp-2016-314295","volume":"87","author":"I Kleffner","year":"2016","unstructured":"Kleffner I, D\u00f6rr J, Ringelstein M, Gross CC, B\u00f6ckenfeld Y, Schwindt W, et al. Diagnostic criteria for Susac syndrome. J Neurol Neurosurg Psychiatry. 2016;87:1287\u201395.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2101_CR10","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1177\/1352458508096878","volume":"14","author":"DH Miller","year":"2008","unstructured":"Miller DH, Weinshenker BG, Filippi M, Banwell BL, Cohen JA, Freedman MS, et al. Differential diagnosis of suspected multiple sclerosis: a consensus approach. Mult Scler. 2008;14:1157\u201374.","journal-title":"Mult Scler"},{"key":"2101_CR11","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/eye.2013.25","volume":"27","author":"DD Varma","year":"2013","unstructured":"Varma DD, Cugati S, Lee AW, Chen CS. A review of central retinal artery occlusion: clinical presentation and management. Eye (Lond). 2013;27:688\u201397.","journal-title":"Eye (Lond)"},{"key":"2101_CR12","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/S0161-6420(81)35080-5","volume":"88","author":"GC Brown","year":"1981","unstructured":"Brown GC, Magargal LE, Shields JA, Goldberg RE, Walsh PN. Retinal arterial obstruction in children and young adults. Ophthalmology. 1981;88:18\u201325.","journal-title":"Ophthalmology"},{"key":"2101_CR13","first-page":"9317232","volume":"2020","author":"SL Fernando","year":"2020","unstructured":"Fernando SL, Boyle T, Smith A, Parratt JDE. The Successful Use of Infliximab in a Relapsing Case of Susac\u2019s Syndrome. Case Rep Neurol Med. 2020;2020:9317232.","journal-title":"Case Rep Neurol Med"},{"key":"2101_CR14","doi-asserted-by":"publisher","first-page":"e66772","DOI":"10.1371\/journal.pone.0066772","volume":"8","author":"AF Tyler","year":"2013","unstructured":"Tyler AF, Mendoza JP, Firan M, Karandikar NJ. CD8(+) T Cells Are Required For Glatiramer Acetate Therapy in Autoimmune Demyelinating Disease. PLoS One. 2013;8:e66772.","journal-title":"PLoS One"},{"key":"2101_CR15","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1001\/jamaneurol.2019.3365","volume":"77","author":"G Luna","year":"2020","unstructured":"Luna G, Alping P, Burman J, Fink K, Fogdell-Hahn A, Gunnarsson M, et al. Infection Risks Among Patients With Multiple Sclerosis Treated With Fingolimod, Natalizumab, Rituximab, and Injectable Therapies. JAMA Neurol. 2020;77:184\u201391.","journal-title":"JAMA Neurol"},{"key":"2101_CR16","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1186\/s12883-020-01892-0","volume":"20","author":"A Wilf-Yarkoni","year":"2020","unstructured":"Wilf-Yarkoni A, Elkayam O, Aizenstein O, Oron Y, Furer V, Zur D, et al. Increased incidence of Susac syndrome: a case series study. BMC Neurol. 2020;20:332.","journal-title":"BMC Neurol"},{"key":"2101_CR17","doi-asserted-by":"publisher","DOI":"10.1007\/s13760-020-01554-5","author":"L Venditti","year":"2020","unstructured":"Venditti L, Rousseau A, Ancelet C, Papo T, Denier C. Susac syndrome following COVID-19 infection. Acta Neurol Belg. 2020. doi:https:\/\/doi.org\/10.1007\/s13760-020-01554-5.","journal-title":"Acta Neurol Belg"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-021-02101-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12886-021-02101-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-021-02101-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,30]],"date-time":"2021-09-30T05:12:22Z","timestamp":1632978742000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcophthalmol.biomedcentral.com\/articles\/10.1186\/s12886-021-02101-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,30]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2101"],"URL":"https:\/\/doi.org\/10.1186\/s12886-021-02101-3","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,30]]},"assertion":[{"value":"31 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not Applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the consent form is available for review by the Editor of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}],"article-number":"352"}}